Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil

Journal of Community Genetics

Volumn 6, Issue 3, 2015, Pages 275-283

  Ashton Prolla, Patrícia ^a,b   Goldim, José Roberto ^a,b   Vairo, Filippo Pinto e ^a   da Silveira Matte, Ursula ^a,b   Sequeiros, Jorge ^c,d,e  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

Ethical issues; Genetic counselling; Genetic testing; Genomic analysis; Informed consent; NGS

Indexed keywords

ARTICLE; BRAZIL; CLINICAL GENETICS; CLINICAL PRACTICE; CLINICAL VALIDITY; GENETIC COUNSELING; GENETIC PROCEDURES; GENETIC SCREENING; GENETIC VARIABILITY; GENOMIC ANALYSIS; GENOMICS; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HETEROZYGOTE; HUMAN; INFORMED CONSENT; LAW; MEDICAL ETHICS; MEDICAL SOCIETY; NEWBORN SCREENING; NEXT GENERATION SEQUENCING; PATIENT; PRIORITY JOURNAL; REIMBURSEMENT; RISK BENEFIT ANALYSIS; STAFF TRAINING; VALIDITY; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING;

EID: 84938745389     PISSN: 1868310X     EISSN: 18686001     Source Type: Journal    
DOI: 10.1007/s12687-015-0238-0     Document Type: Article

References (79)

1. ACMG (American College of Medical Genetics) Board of Directors (2013) Points to consider for informed consent for genome/exome sequencing. Genet Med 15:748–749
2. Abul-Husn NS, Owusu Obeng A, Sanderson SC et al (2014) Implementation and utilization of genetic testing in personalized medicine. Pharm Pers Med 13:227–240. doi:10.2147/PGPM.S48887. eCollection 2014
3. Annas GJ, Elias S (2014) 23andMe and the FDA. N Engl J Med 370:985–988. doi:10.1056/NEJMp1316367
4. ANS (2013) Anex of Document 876/GGRAS/DIPRO/ANS of Dec 4th 2013. Available at http://www.ans.gov.br/images/stories/noticias/pdf/anexo%20nota%20tcnica%20analise%20molecular%20de%20dna.pdf. Accessed 25 May 2015
5. Apellániz-Ruiz M, Lee MY, Sánchez-Barroso L, Gutiérrez-Gutiérrez G, Calvo I, García-Estévez L, Sereno M, García-Donás J, Castelo B, Guerra E, Leandro-García LJ, Cascón A, Johansson I, Robledo M, Ingelman-Sundberg M, Rodríguez-Antona C (2015) Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy. Clin Cancer Res 21(2):322–328. doi:10.1158/1078-0432.CCR-14-1758
6. Appelbaum OS, Parens E, Waldman CR et al (2014) Models of consent to return of incidental findings in genomic research. Hastings Cent Rep 44:22–32
7. Becker F, van El CG, Ibarreta D et al (2011) Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background document to the ESHG recommendations on genetic testing and common disorders. Eur J Hum Genet 19(Suppl 1):S6–S44
8. Beckmann JS (2014) Can we afford to sequence every newborn baby’s genome? Hum Mutat. doi:10.1002/humu.22748
9. Biehl J, Amon JJ, Socal MP, Petryna A (2012) Between the court and the clinic: lawsuits for medicines and the right to health in Brazil. Health Hum Rights 14:E36–E52
10. Bonnefond A, Froguel P (2013) Next-generation sequencing for identifying new genes in rare genetic diseases: many challenges and a pinch of luck. Genome Biol 29:309
11. Borovik CL, Tajara EH, Rocha JC et al. (2004) Guia de boas práticas laboratoriais em citogenética e genética molecular humana. Sociedade Brasileira de Genética. Available at: http://www2.ib.unicamp.br/caeb/Eduardo%20Becker/art%2016.pdf. Accessed 14 Feb 2015
12. Borry P, van Hellemondt RE, Sprumont D et al (2012) Legislation on direct-to-consumer genetic testing in seven European countries. Eur J Hum Genet 20:715–721
13. Boycott KM, Vanstone MR, Bulman DE et al (2013) Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 14:681–691
14. Bras J, Guerreiro R, Hardy J (2012) Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat Rev Neurosci 13:453–464
15. BRASIL (1988) Constituição da República Federativa do Brasil de 1988. Brasília, 1988
16. BRASIL (1995) Law 11.105/1995 of March 24th 2005. Available at: http://www.planalto.gov.br/ccivil_03/_ato2004-2006/2005/lei/l11105.htm. Accessed 25 May 2015
17. BRASIL (2002) Código Civil Brasileiro: Lei 10. 406, de 10 de janeiro de 2002. Brasília, 2002
18. BRASIL (2012) Conselho Nacional de Saúde. Resolução 466/2012. Diretrizes e normas regulamentadoras de pesquisas. Available at: http://conselho.saude.gov.br/resolucoes/2012/Reso466.pdf. Accessed 5 Feb 2015
19. BRASIL (2013) Agência Nacional de Saúde Suplementar. Resolução Normativa RN N° 338, de 21 out 2013. Available at: http://www.ans.gov.br/index2.php?option=com_legislacao&view=legislacao&task=TextoLei&format=raw&id=2591. Accessed 3 Feb 2014
20. BRASIL (2014) Ministério da Educação. Câmara de Educação Superior. Resolução N° 3, de 20 jun 2014. Diretrizes Curriculares Nacionais do Curso de Graduação em Medicina. Diário Oficial da União Seção 1. N° 117, 23 Jun 2014. Available at: http://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=23/06/2014&jornal=1&pagina=11&totalArquivos=64. Accessed 3 Feb 2014
21. BRASIL (2014) Ministério da Saúde. Portaria N° 199, de 30 de janeiro de 2014. Política Nacional de Atenção Integral às Pessoas com Doenças Raras. Diretrizes para Atenção Integral às Pessoas com Doenças Raras no âmbito do SUS. Available at: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2014/prt0199_30_01_2014.html. Accessed 3 Feb 2015
22. Cadwalladr C (2013) What happened when I had my genome sequenced. Available at: http://www.theguardian.com/science/2013/jun/08/genome-sequenced. Accessed 3 Feb 2015
23. Clarke AJ (2014) Managing the ethical challenges of next-generation sequencing in genomic medicine. Br Med Bull 111:17–30
24. Claustres M, Kožich V, Dequeker E et al (2014) Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic). Eur J Hum Genet 22:160–170
25. Collins FS, Green ED, Guttmacher AE et al (2003) Institute US National Human Genome Research Institute. A vision for the future of genomics research. Nature 422:835–847
26. Dixon-Salazar TJ, Silhavy JL, Udpa N et al (2012) Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med 13:138ra78
27. Dorey E (2013) Newborns sequenced at NIH. Nat Biotechnol 31:948
28. Drögemöller BI, Wright GE, Niehaus DJ et al (2013) Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment. Pharmacogenet Genomics 23:666–674
29. ESHG (European Society of Human Genetics) (2010) Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes. Eur J Hum Genet 18:1271–1273
30. Farndon PA, Bennett C (2008) Genetics education for health professionals: strategies and outcomes from a national initiative in the United Kingdom. J Genet Couns 17:161–169
31. Filges I, Friedman JM (2014) Exome sequencing for gene discovery in lethal fetal disorders—harnessing the value of extreme phenotypes. Prenat Diagn. doi:10.1002/pd.4464
32. Gracia-Aznarez FJ, Fernandez V, Pita G et al (2013) Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles. PLoS ONE 8:e55681. doi:10.1371/journal.pone.0055681
33. Green RC, Berg JS, Grody WW et al (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15:565–574
34. Guchelaar HJ, Gelderblom H, van der Straaten T et al (2014) Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing. Clin Pharmacol Ther 95:383–385
35. Guttmacher AE, Porteous ME, McInerney JD (2007) Educating health-care professionals about genetics and genomics. Nat Rev Genet 8:151–157
36. Hechtman JF, Zehir A, Mitchell T et al (2015) Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal tumors revealed by next generation sequencing. Genes Chromosom Cancer 54:177–184
37. Horovitz DD, de Faria Ferraz VE, Dain S et al (2013) Genetic services and testing in Brazil. J Community Genet 4:355–375
38. Jacob HJ, Abrams K, Bick DP, Brodie K, Dimmock DP, Farrell M, Geurts J, Harris J, Helbling D, Joers BJ, Kliegman R, Kowalski G, Lazar J, Margolis DA, North P, Northup J, Roquemore-Goins A, Scharer G, Shimoyama M, Strong K, Taylor B, Tsaih SW, Tschannen MR, Veith RL, Wendt-Andrae J, Wilk B, Worthey EA (2013) Genomics in clinical practice: lessons from the front lines. Sci Transl Med 5(194):194cm5. doi:10.1126/scitranslmed.3006468
39. Johansen Taber KA, Dickinson BD, Wilson M (2014) The promise and challenges of next-generation genome sequencing for clinical care. JAMA Intern Med 174:275–280
40. Kirk M, Tonkin E, Burke S (2008) Engaging nurses in genetics: the strategic approach of the NHS National Genetics Education and Development Centre. J Genet Couns 17:180–188
41. Knoppers BM, Sénécal K, Borry P et al (2014) Whole-genome sequencing in newborn screening programs. Sci Transl Med 6:229cm2. doi:10.1126/ scitranslmed.3008494
42. Lebofsky R, Decraene C, Bernard V et al (2014) Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types. Mol Oncol. doi:10.1016/j.molonc. 2014.12.003
43. Leite TKM, Fonseca RMC, de França NM et al (2011) Genomic ancestry, self-reported “color” and quantitative measures of skin pigmentation in Brazilian admixed siblings. PLoS One 6:e27162. doi:10.1371/jornal.pone.0027162
44. Lin E, Chien J, Ong FS et al (2015) Challenges and opportunities for next-generation sequencing in companion diagnostics. Expert Rev Mol Diagn 15:193–209
45. Lopes-Cendes I, Rocha JCC, Jardim LB (2001) Testes Preditivos. In: Projeto Diretrizes - Associação Médica Brasileira e Conselho Federal de Medicina. Available at: www.projetodiretrizes.org.br/projeto_diretrizes/091.pdf. Accessed 14 Feb 2015
46. Macchini K, Douglas J, Braxton A et al (2014) Genetic counselor’s views and experiences with the clinical integration of genome sequencing. J Genet Couns 23:496–505
47. Melo DG, Sequeiros J (2012) The challenges of incorporating genetic testing in the unified national health system in Brazil. Genet Test Mol Biomarkers 16:651–655
48. Moreira AL, Eng J (2014) Personalized therapy for lung cancer. Chest 146:1649–1657
49. Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, McDonald MT, Meisler MH, Goldstein DB (2012) Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet 49(6):353–361. doi:10.1136/jmedgenet-2012-100819
50. Newman WG, Black GC (2014) Delivery of a clinical genomics service. Genes (Basel) 6:1001–1017
51. Nigro V, Piluso G (2012) Next generation sequencing (NGS) strategies for the genetic testing of myopathies. Acta Myol 31:196–200
52. Ormond KE, Cho MK (2014) Translating personalized medicine using new genetic technologies in clinical practice: the ethical issues. Per Med 11:211–222
53. Paim J, Travassos C, Almeida C et al (2011) The Brazilian health system: history, advances, and challenges. Lancet 377:1778–1797
54. Passos-Bueno MR, Bertola D, Horovitz DD, de Faria Ferraz VE, Brito LA (2014) Genetics and genomics in Brazil: a promising future. Mol Genet Genomic Med 2(4):280–291
55. Pena SD, Di Pietro G, Fuchshuber-Moraes M et al (2011) The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One 6:e17063
56. Pietrobon L, Prado ML, Caetano JC (2008) Supplemental health in Brazil: the role of the National Agency of Supplemental Health in the sector’s regulation. Physis 18:767–783
57. Pinxten W, Howard HC (2014) Ethical issues raised by whole genome sequencing. Best Pract Res Clin Gastroenterol 2:269–279
58. Prior TW (2014) Next-generation carrier screening: are we ready? Genome Med 6:62–64
59. Rabbani B, Mahdieh N, Hosomichi K et al (2012) Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders. J Hum Genet 57:621–632
60. Raskin S, Perez ABA, Marques-de-Faria AP (2004) Genética Médica: Teste Laboratorial para Diagnóstico de Doenças Sintomáticas. In: Projeto Diretrizes - Associação Médica Brasileira e Conselho Federal de Medicina. Available at: www.projetodiretrizes.org.br/projeto_diretrizes/054.pdf. Accessed 14 Feb 2015
61. Rehm HL (2013) Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 14:295–300
62. Rehm HL, Bale SJ, Bayrak-Toydemir P et al (2013) ACMG clinical laboratory standards for next-generation sequencing. Genet Med 15:733–747
63. Richards CS, Bale S, Bellissimo DB et al (2008) ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007. Genet Med 10:294–300
64. Rogowski WH, Grosse SD, Khoury MJ (2009) Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet 10:489–495
65. SBGM (Sociedade Brasileira de Genética Médica) (2014) Residência Médica. Available at: http://www.sbgm.org.br/residencia.asp. Accessed 3 Feb 2015
66. Schnekenberg RP, Németh AH (2014) Next-generation sequencing in childhood disorders. Arch Dis Child 99:284–290
67. Soden SE, Saunders CJ, Willig LK et al (2014) Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med 6:265ra168
68. South ST, Lee C, Lamb AN et al (2013) ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med 15:901–909
69. The World Bank (2014) Gini Index. World Bank Estimate. Available at: http://data.worldbank.org/indicator/SI.POV.GINI. Accessed 7 Feb 2015
70. Townsend A, Adam S, Birch PH et al (2013) Paternalism and the ACMG recommendations on genomic incidental findings: patients seen but not heard. Genet Med 15:751–752
71. Toledo RA, Sekiya T, Longuini VC et al (2012) Narrowing the gap of personalized medicine in emerging countries: the case of multiple endocrine neoplasias in Brazil. Clinics (São Paulo) 67(Suppl 1):3–6
72. UNDP (United Nations Development Program) (2013) Human Development Reports. Brazil. Available at http://hdr.undp.org/en/countries/profiles/BRA. Accessed 5 Feb 2015
73. United Nations Economic and Social Council (ECOSOC) (2004) Resolution 2004/9. Genetic privacy and non-discrimination. Available at: http://www.un.org/en/ecosoc/docs/2004/resolution%202004-9.pdf. Accessed 5 May 2015
74. Van Allen EM, Wagle N, Stojanov P et al (2014) Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med 20:682–688
75. Vrijenhoek T, Kraaijeveld K, Elferink M et al (2015) Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects. Eur J Hum Genet. doi:10.1038/ejhg.2014.279
76. Xu Z, Geng Q, Luo F et al (2014) Multiplex ligation-dependent probe amplification and array comparative genomic hybridization analyses for prenatal diagnosis of cytogenomic abnormalities. Mol Cytogenet 7:84–93
77. Zhang X (2014) Exome sequencing greatly expedites the progressive research of Mendelian diseases. Front Med 8:42–57
78. Zhu X, Petrovski S, Xie P, Ruzzo EK, Lu YF, McSweeney KM, Ben-Zeev B, Nissenkorn A, Anikster Y, Oz-Levi D, Dhindsa RS, Hitomi Y, Schoch K, Spillmann RC, Heimer G, Marek-Yagel D, Tzadok M, Han Y, Worley G, Goldstein J, Jiang YH, Lancet D, Pras E, Shashi V, McHale D, Need AC, Goldstein DB (2015) Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet Med. doi:10.1038/gim.2014.191
79. Wetterstrand KA (2014) DNA sequencing costs: data from the NHGRI Genome Sequencing Program (GSP). Available at: www.genome.gov/sequencingcosts. Accessed 3 Feb 2015